Saturday 17 October 2026
Export ATEC’s income statement to Excel — free account
Alphatec Holdings, Inc.
ATEC Healthcare Medical Devices
Alphatec Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $764.2 million, up 25.0% from fiscal 2024. In the quarter to June 2026, revenue grew 15.1%, EPS grew 40.7%, free cash flow fell 146.9% and total debt fell 7.79%, each against the same quarter a year earlier. Revenue growth for five consecutive years; insiders bought in the last twelve months.
10.45
0.48
−4.39%
Follow ATEC
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
6 | 6 | 6 | 6 |
+8 more TTM periods Free account |
| (1,879.90%) | 274.65% | 16,450.51% | (3,055.22%) | ||
| (13.91%) | (15.82%) | (18.30%) | (20.21%) | ||
ROIC |
(8.10%) | (10.41%) | (14.54%) | (14.61%) | |
Return on Tangible Assets |
(31.40%) | (35.41%) | (39.06%) | (43.38%) | |
Average Days of Receivables |
49.32 | 49.33 | 46.48 | 48.55 | |
Free Cash Flow per Share |
(0.04) | (0.01) | (0.03) | (0.02) | |
Free Cash Flow |
(5.74) | (0.78) | (4.41) | (3.35) | |
Capital Expenditures |
(62.26) | (52.34) | (49.64) | (38.42) | |
| Other line items | |||||
Cash ROIC |
(0.93%) | (0.12%) | (0.65%) | (0.46%) | |
Accounts Receivable Turnover |
7.91 | 8.04 | 8.48 | 8.31 | |
Accounts Payable Turnover |
4.62 | 5.89 | 5.27 | 4.98 | |
Inventory Turnover |
1.39 | 1.40 | 1.44 | 1.37 | |
Average Days of Payables |
89.69 | 67.28 | 60.35 | 56.01 | |
Days of Inventory on Hand |
281.44 | 271.84 | 250.06 | 253.50 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
9.46% | 9.81% | 9.98% | 10.55% | |
Selling, General and Administrative Expense of Revenue |
64.30% | 64.61% | 65.24% | 66.55% | |
Share Based Compensation of Revenue |
9.52% | 9.54% | 9.65% | 10.42% | |
Interest Coverage |
(1.02) | (1.21) | (1.79) | (2.42) | |
Operating CF/Net income |
(0.51) | (0.41) | (0.32) | (0.23) | |
Depreciation/Fixed assets |
0.80 | 0.79 | 0.78 | 0.73 | |
Capex/Depreciation |
(0.56) | (0.48) | (0.47) | (0.38) | |
Revenue per Share |
5.21 | 5.11 | 5.09 | 4.81 | |
Operating CF per Share |
0.36 | 0.33 | 0.30 | 0.23 | |
Capex per Share |
(0.40) | (0.34) | (0.33) | (0.25) | |
Capex to Sales |
0.08 | 0.07 | 0.07 | 0.05 |
Columns are period end dates